HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 50704,
"recordsTotal": 50704,
"next": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=-days_late&start=47100",
"previous": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=-days_late&start=46500",
"results": [
{
"registry_id": "NCT07290777",
"publication_url": "https://clinicaltrials.gov/study/NCT07290777",
"title": "A Phase 2, Randomized, Partially Blinded, Controlled, Dose-ranging Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of VEL-101 in Kidney Transplant Recipients.",
"has_exemption": false,
"start_date": "2026-08-18",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Veloxis Pharmaceuticals",
"sponsor_slug": "veloxis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07766018",
"publication_url": "https://clinicaltrials.gov/study/NCT07766018",
"title": "A Phase 2 Open-Label, Single-Arm, Multicenter Trial to Evaluate the Efficacy and Safety of Elacestrant Monotherapy for the Treatment of Japanese Participants With ER+/HER2- Advanced or Metastatic Breast Cancer With ESR1-mutation Following CDK4/6 Inhibitor Therapy",
"has_exemption": false,
"start_date": "2026-08-18",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stemline Therapeutics, Inc.",
"sponsor_slug": "stemline-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07783542",
"publication_url": "https://clinicaltrials.gov/study/NCT07783542",
"title": "A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ORKA-002 in Adult Participants With Moderate-to-Severe Hidradenitis Suppurativa",
"has_exemption": false,
"start_date": "2026-08-21",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Oruka Therapeutics, Inc.",
"sponsor_slug": "oruka-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07705555",
"publication_url": "https://clinicaltrials.gov/study/NCT07705555",
"title": "A Randomized, Double-Masked, Multicenter, 3-Arm, Pivotal Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal (IVT) MK-8748 Compared With Aflibercept (2 mg) in Participants With Diabetic Macular Edema (DME)",
"has_exemption": false,
"start_date": "2026-08-27",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07135687",
"publication_url": "https://clinicaltrials.gov/study/NCT07135687",
"title": "Oral Losartan to Decrease the Risk of Postoperative Arthrofibrosis Following Primary and Revision Anterior Cruciate Ligament Reconstruction",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rush University Medical Center",
"sponsor_slug": "rush-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07680439",
"publication_url": "https://clinicaltrials.gov/study/NCT07680439",
"title": "A Phase 2 Pivotal Study of BCB-276, a B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BrainChild Bio, Inc",
"sponsor_slug": "brainchild-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07742735",
"publication_url": "https://clinicaltrials.gov/study/NCT07742735",
"title": "A Parallel-group Treatment, Phase 3, Double-blind, Randomized, 2-arm Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF)",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VectivBio AG",
"sponsor_slug": "vectivbio-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07755904",
"publication_url": "https://clinicaltrials.gov/study/NCT07755904",
"title": "A Phase 3, Multi-region, Multi-center, Randomized, Double-blind, Active-Comparator-Controlled Trial to Evaluate the Efficacy and Safety of BHB-1893 Compared to Metoprolol in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy",
"has_exemption": false,
"start_date": "2026-09-02",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Braveheart Bio, Inc.",
"sponsor_slug": "braveheart-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07619482",
"publication_url": "https://clinicaltrials.gov/study/NCT07619482",
"title": "A Phase 1/2 Dose Escalation Followed by a Masked, Randomized, Placebo-Controlled Study to Evaluate Topical Insulin for Neuroprotection in Open Angle Glaucoma",
"has_exemption": false,
"start_date": "2026-09-10",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07713199",
"publication_url": "https://clinicaltrials.gov/study/NCT07713199",
"title": "Free Soft Tissue Grafts (FSTG) Using Autograft Palatal Donor Tissue vs. Xenograft Collagen Soft Tissue Matrix From Porcine Achilles Tendon (Zderm™)",
"has_exemption": false,
"start_date": "2026-09-15",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center at San Antonio",
"sponsor_slug": "the-university-of-texas-health-science-center-at-san-antonio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07745374",
"publication_url": "https://clinicaltrials.gov/study/NCT07745374",
"title": "Deep Brain Stimulation for Bipolar Depression: Assessing the Safety and Use of Intracranial Neurophenotyping of State Switches",
"has_exemption": false,
"start_date": "2026-09-21",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07793435",
"publication_url": "https://clinicaltrials.gov/study/NCT07793435",
"title": "A Phase 1/2 Trial of ADI-212 (Engineered γδ Chimeric Antigen Receptor [CAR] Vδ1 T Cells Targeting PSMA) in Adults With Metastatic Castration-Resistant Prostate Cancer (mCRPC)",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Adicet Therapeutics",
"sponsor_slug": "adicet-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07852312",
"publication_url": "https://clinicaltrials.gov/study/NCT07852312",
"title": "Clinical Outcomes of Root Canal Treatment Using Modern Irrigation Protocols",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07819175",
"publication_url": "https://clinicaltrials.gov/study/NCT07819175",
"title": "Pulsed Field Ablation for the Treatment of Persistent Atrial Fibrillation: Pulmonary Vein Plus Superior Vena Cava Isolation Versus Pulmonary Vein Isolation Alone-A Prospective, Multicenter, Randomized Controlled Study",
"has_exemption": false,
"start_date": "2026-10-08",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ruijin Hospital",
"sponsor_slug": "ruijin-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05855694",
"publication_url": "https://clinicaltrials.gov/study/NCT05855694",
"title": "Pilot Study of Photobiomodulation for Cancer-Related Cognitive Impairment",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Arash Asher, MD",
"sponsor_slug": "arash-asher-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06258525",
"publication_url": "https://clinicaltrials.gov/study/NCT06258525",
"title": "A Phase II, Open-Label Trial of S-Adenosylmethionine (SAMe) in Prevention of Oxaliplatin Associated Liver Injury",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cedars-Sinai Medical Center",
"sponsor_slug": "cedars-sinai-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06272201",
"publication_url": "https://clinicaltrials.gov/study/NCT06272201",
"title": "Incisionless Suture Plications in a POSE2.0 Interventional Randomized Obesity Study (The INSPIRO Study)",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "USGI Medical",
"sponsor_slug": "usgi-medical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06675435",
"publication_url": "https://clinicaltrials.gov/study/NCT06675435",
"title": "The Effect of Inhaled Nitric Oxide on Intrapulmonary Shunt in Acutely Hypoxemic Patients With Severe Obesity",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224711",
"publication_url": "https://clinicaltrials.gov/study/NCT07224711",
"title": "The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery (IMPALA ERAS)",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07634393",
"publication_url": "https://clinicaltrials.gov/study/NCT07634393",
"title": "A Randomized Study of Intravenous Metoclopramide Versus Intravenous Acetaminophen for Acute Concussion Treatment",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Montefiore Medical Center",
"sponsor_slug": "montefiore-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07678242",
"publication_url": "https://clinicaltrials.gov/study/NCT07678242",
"title": "The Lucida Project",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07800871",
"publication_url": "https://clinicaltrials.gov/study/NCT07800871",
"title": "An Open-Label, Multicenter, Phase 1/2 Dose-Escalation and Expansion Trial Evaluating the Safety and Efficacy of FT839 in Participants With Autoimmune Diseases",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Fate Therapeutics",
"sponsor_slug": "fate-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07814755",
"publication_url": "https://clinicaltrials.gov/study/NCT07814755",
"title": "Auricular Vagal Neuromodulation Therapy (AVNT™) for the Alleviation of Depression and Anxiety in Substance Use Disorder",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Daisy Thompson-Lake",
"sponsor_slug": "daisy-thompson-lake",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07819214",
"publication_url": "https://clinicaltrials.gov/study/NCT07819214",
"title": "Epcoritamab as Consolidation Therapy for High-risk Patients With Chronic Lymphocytic Leukemia on Bruton Tyrosine Kinase Inhibitor",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Irvine",
"sponsor_slug": "university-of-california-irvine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07845552",
"publication_url": "https://clinicaltrials.gov/study/NCT07845552",
"title": "Oral Food Challenge After One to Two Doses of Omalizumab Treatment for Food Allergy",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07856823",
"publication_url": "https://clinicaltrials.gov/study/NCT07856823",
"title": "First-Principles Mapping of Regional Fermentation Physiology in the Human Intestine With Ingestible Capsules",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07728214",
"publication_url": "https://clinicaltrials.gov/study/NCT07728214",
"title": "Reminder-enhanced Incentive Spirometry Evaluation (RISE)",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07880197",
"publication_url": "https://clinicaltrials.gov/study/NCT07880197",
"title": "The AC/DCP Trial: Assessment of Closure, Dehiscence, and Aesthetics in Cerebral Palsy Multilevel Surgery. A Randomized, Double-Blinded, Split-Body Trial of Knotless Tissue Control Devices Versus Conventional Suture",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05882344",
"publication_url": "https://clinicaltrials.gov/study/NCT05882344",
"title": "Cholinergic Deep Brain Stimulation for Alzheimer's Disease",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07738510",
"publication_url": "https://clinicaltrials.gov/study/NCT07738510",
"title": "A Phase 2b, Multicenter, Open-Label, Dose-Escalation, and Randomized Dose-Optimization Study of Ofirnoflast (HT-6184) for the Treatment of Myelodysplastic Syndromes in Adults With Very Low- to Intermediate-Risk Myelodysplastic Syndromes Requiring Red Blood Cell Transfusions",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Halia Therapeutics, Inc.",
"sponsor_slug": "halia-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07868939",
"publication_url": "https://clinicaltrials.gov/study/NCT07868939",
"title": "A Phase 3 Randomized, Double-Blind, Placebo-Controlled, 68-Week Efficacy and Safety Study of VK2735 Administered Orally for Weight Management in Participants With Type 2 Diabetes Mellitus Who Are Obese, or Overweight",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Viking Therapeutics, Inc.",
"sponsor_slug": "viking-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06205589",
"publication_url": "https://clinicaltrials.gov/study/NCT06205589",
"title": "A Phase 2a/2b Study Evaluating Safety, Immunogenicity, and Therapeutic Efficacy of ID93 + GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections",
"sponsor_slug": "advancing-clinical-therapeutics-globally-for-hivaids-and-other-infections",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06916325",
"publication_url": "https://clinicaltrials.gov/study/NCT06916325",
"title": "DeLIVER Trial: A Prospective, Multi-Center, Single-Arm, Open Label Trial of Deceased Donor Livers Transplanted After DHOPE With eXVIVO LIVER Perfusion",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "XVIVO Perfusion",
"sponsor_slug": "xvivo-perfusion",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05251181",
"publication_url": "https://clinicaltrials.gov/study/NCT05251181",
"title": "A Multi-Centric, Randomized, Double-Blind, Placebo-controlled, Phase-III Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent to be Used as an Adjuvant to Standard Treatment of Hypovolemic Shock",
"has_exemption": false,
"start_date": "2027-02-28",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Pharmazz, Inc.",
"sponsor_slug": "pharmazz-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224698",
"publication_url": "https://clinicaltrials.gov/study/NCT07224698",
"title": "Phase 2 Multicenter Randomized Placebo-controlled, Double-blind, Parallel Study to Assess the Safety and Efficacy of Inhaled Cannabis in Veterans for Treatment of Posttraumatic Stress Disorder (PTSD)",
"has_exemption": false,
"start_date": "2027-02-28",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Multidisciplinary Association for Psychedelic Studies",
"sponsor_slug": "multidisciplinary-association-for-psychedelic-studies",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04266275",
"publication_url": "https://clinicaltrials.gov/study/NCT04266275",
"title": "An Investigation in the Use of Curcumin Topical Herbal Agent for the Treatment of Cervical Intraepithelial Neoplasia",
"has_exemption": false,
"start_date": "2027-04-30",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Lisa Flowers",
"sponsor_slug": "lisa-flowers",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07736105",
"publication_url": "https://clinicaltrials.gov/study/NCT07736105",
"title": "Optimizing Dysphagia Treatment Delivery in Acute Care: A Hybrid Efficacy Implementation Trial",
"has_exemption": false,
"start_date": "2027-07-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05276011",
"publication_url": "https://clinicaltrials.gov/study/NCT05276011",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Determine the Efficacy, Safety, and Dosing of TG-C in Adult Subjects With Symptomatic Early Hip Osteoarthritis",
"has_exemption": false,
"start_date": "2027-10-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kolon TissueGene, Inc.",
"sponsor_slug": "kolon-tissuegene-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04893109",
"publication_url": "https://clinicaltrials.gov/study/NCT04893109",
"title": "A Randomized Phase II Trial of Adjuvant Trastuzumab Emtansine (T-DM1) Followed by Subcutaneous Trastuzumab Versus Paclitaxel in Combination With Subcutaneous Trastuzumab for Stage I HER2-positive Breast Cancer (ATEMPT 2.0)",
"has_exemption": false,
"start_date": "2021-06-16",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03934905",
"publication_url": "https://clinicaltrials.gov/study/NCT03934905",
"title": "Phase II Trial of Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction (CRI18-026)",
"has_exemption": false,
"start_date": "2022-06-01",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Texas Tech University Health Sciences Center",
"sponsor_slug": "texas-tech-university-health-sciences-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06053658",
"publication_url": "https://clinicaltrials.gov/study/NCT06053658",
"title": "Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma",
"has_exemption": false,
"start_date": "2024-01-05",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06080503",
"publication_url": "https://clinicaltrials.gov/study/NCT06080503",
"title": "G-FORCE: Phase II Randomized Study of Glottic Larynx Hypofractionated Radiotherapy Versus ConvEntional Radiotherapy",
"has_exemption": false,
"start_date": "2024-03-14",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06709495",
"publication_url": "https://clinicaltrials.gov/study/NCT06709495",
"title": "Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas",
"has_exemption": false,
"start_date": "2025-01-27",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "David S Shulman, MD",
"sponsor_slug": "david-s-shulman-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06819007",
"publication_url": "https://clinicaltrials.gov/study/NCT06819007",
"title": "A Phase 3, Open-label, Multicenter, Randomized Trial of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy as First-line Maintenance Therapy in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01/ENGOT-ov89/GEICO144- O/GOG-3112/APGOT-OV13)",
"has_exemption": false,
"start_date": "2025-03-19",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06973629",
"publication_url": "https://clinicaltrials.gov/study/NCT06973629",
"title": "A Two-Part Phase 3b Randomized, Double-Blind, Placebo-Controlled, Followed by Open-Label Extension, Multicenter Study of the Efficacy and Safety of MSC-NTF (NurOwn) in Participants With With Early Symptomatic and Moderate Disease Presentation in Amyotrophic Lateral Sclerosis (ALS)",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brainstorm-Cell Therapeutics",
"sponsor_slug": "brainstorm-cell-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07217301",
"publication_url": "https://clinicaltrials.gov/study/NCT07217301",
"title": "A Randomized, Open Label, Multicenter, Phase 3 Trial Evaluating the Efficacy and Safety of TAK-928 Versus Docetaxel in Participants With Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Disease Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy",
"has_exemption": false,
"start_date": "2025-11-26",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07408232",
"publication_url": "https://clinicaltrials.gov/study/NCT07408232",
"title": "A Phase 1/2, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of OCT-980 in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa",
"has_exemption": false,
"start_date": "2026-03-10",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Octant, Inc.",
"sponsor_slug": "octant-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07283731",
"publication_url": "https://clinicaltrials.gov/study/NCT07283731",
"title": "Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma",
"has_exemption": false,
"start_date": "2026-04-14",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06909539",
"publication_url": "https://clinicaltrials.gov/study/NCT06909539",
"title": "Using a Perineometer Device With Gamification to Improve Symptom Outcomes in Pediatric Pelvic Floor Dysfunction",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07126561",
"publication_url": "https://clinicaltrials.gov/study/NCT07126561",
"title": "Phase II Open Label Trial of Trastuzumab Deruxtecan (Enhertu, DS-8210) in HER2 Positive Newly Diagnosed Metastatic Esophageal, Gastric, GEJ Cancer Patients With an ECOG Performance Status of 2",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07796490",
"publication_url": "https://clinicaltrials.gov/study/NCT07796490",
"title": "A Pilot Randomized, Single Blind, Placebo Controlled Study of Neoadjuvant Intraprostatic OnabotulinumtoxinA Prior to Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The Methodist Hospital Research Institute",
"sponsor_slug": "the-methodist-hospital-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07879716",
"publication_url": "https://clinicaltrials.gov/study/NCT07879716",
"title": "Belgo-Luxembourg Collaborative Research Network on AVEIR Leadless Pacemakers",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Universitaire Ziekenhuizen KU Leuven",
"sponsor_slug": "universitaire-ziekenhuizen-ku-leuven",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07538336",
"publication_url": "https://clinicaltrials.gov/study/NCT07538336",
"title": "Targeting Interferon Gamma With Emapalumab to Lung Transplant Recipients With Interferon Gamma-high Acute Lung Allograft Dysfunction",
"has_exemption": false,
"start_date": "2026-11-02",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07874841",
"publication_url": "https://clinicaltrials.gov/study/NCT07874841",
"title": "Varenicline for Smoking Cessation in Pancreatitis: An Open-Label Trial",
"has_exemption": false,
"start_date": "2026-11-13",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07612007",
"publication_url": "https://clinicaltrials.gov/study/NCT07612007",
"title": "Phase 2B Study to Determine Efficacy of HRX215, a First Generation MKK4 Inhibitor Drug, in Improving Regeneration of the Remnant Liver After Portal Vein Embolization (PVE) of Colorectal Liver Metastasis (CRLM)",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06152237",
"publication_url": "https://clinicaltrials.gov/study/NCT06152237",
"title": "A Multicenter, Open Label, Randomized, Dose-Escalation and Dose-Expansion Study of the Safety, Tolerability, and Efficacy of a Single Intrathecal Administration of TSHA-102, an AAV9-Delivered Gene Therapy, for the Treatment of Pediatric Females With Rett Syndrome",
"has_exemption": false,
"start_date": "2023-12-12",
"completion_date": "2028-11-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Taysha Gene Therapies, Inc.",
"sponsor_slug": "taysha-gene-therapies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07011745",
"publication_url": "https://clinicaltrials.gov/study/NCT07011745",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)",
"has_exemption": false,
"start_date": "2025-07-16",
"completion_date": "2028-11-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06189313",
"publication_url": "https://clinicaltrials.gov/study/NCT06189313",
"title": "A Prospective, Multicenter Study to Evaluate the Safety and Efficacy of an Aspiration Thrombectomy System in Acute Pulmonary Embolism",
"has_exemption": false,
"start_date": "2025-01-03",
"completion_date": "2028-11-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Argon Medical Devices",
"sponsor_slug": "argon-medical-devices",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06690177",
"publication_url": "https://clinicaltrials.gov/study/NCT06690177",
"title": "A Multicenter, Prospective, Randomized, Placebo and Non-Surgical Standard of Care (NSSOC) Controlled Study, Performed to Evaluate the Safety and Efficacy of EscharEx and Its Placebo (Gel Vehicle) Compared to NSSOC in Participants With Venous Leg Ulcers (VLU)",
"has_exemption": false,
"start_date": "2027-01-10",
"completion_date": "2028-11-04",
"has_results": false,
"results_due": false,
"sponsor_name": "MediWound Ltd",
"sponsor_slug": "mediwound-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07160244",
"publication_url": "https://clinicaltrials.gov/study/NCT07160244",
"title": "A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLINDED TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MULTIVALENT GROUP B STREPTOCOCCUS VACCINE IN HEALTHY PREGNANT WOMEN AND THEIR INFANTS",
"has_exemption": false,
"start_date": "2025-08-25",
"completion_date": "2028-11-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07772531",
"publication_url": "https://clinicaltrials.gov/study/NCT07772531",
"title": "A Phase 2, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Monotherapy, Multicenter Study to Evaluate the Efficacy and Safety of BMS-986511 in Two Sequential Parts in Participants With Major Depressive Disorder",
"has_exemption": false,
"start_date": "2026-10-30",
"completion_date": "2028-11-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04590326",
"publication_url": "https://clinicaltrials.gov/study/NCT04590326",
"title": "A Phase 1/2 Study of REGN5668 (MUC16xCD28, a Costimulatory Bispecific Antibody) Administered in Combination With Other Agents in MUC16 + Malignancies",
"has_exemption": false,
"start_date": "2020-12-08",
"completion_date": "2028-11-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06504394",
"publication_url": "https://clinicaltrials.gov/study/NCT06504394",
"title": "A Phase 2 Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)",
"has_exemption": false,
"start_date": "2024-10-14",
"completion_date": "2028-11-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03516617",
"publication_url": "https://clinicaltrials.gov/study/NCT03516617",
"title": "Randomized Phase 2 Study Comparing Acalabrutinib to Acalabrutinib and Obinutuzumab in the Treatment of Patients With Early-Stage Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Who Are at High Risk of Disease Progression",
"has_exemption": false,
"start_date": "2018-09-10",
"completion_date": "2028-11-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04375800",
"publication_url": "https://clinicaltrials.gov/study/NCT04375800",
"title": "A Phase 2 Clinical Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in Participants With HIV-1, Who Are 4 Weeks to Less Than 12 Years of Age and Weigh Less Than 45 kg",
"has_exemption": false,
"start_date": "2021-02-03",
"completion_date": "2028-11-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06161519",
"publication_url": "https://clinicaltrials.gov/study/NCT06161519",
"title": "Phase I/II Trial of PLX038 in Primary Central Nervous System Tumors With and Without MYC or MYCN Amplifications",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2028-11-14",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07301034",
"publication_url": "https://clinicaltrials.gov/study/NCT07301034",
"title": "Effects of Ziltivekimab Versus Placebo on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction. A Serial, Multivessel, Intravascular Ultrasound, Near-infrared Spectroscopy and Optical Coherence Tomography Imaging Study",
"has_exemption": false,
"start_date": "2025-12-18",
"completion_date": "2028-11-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07335562",
"publication_url": "https://clinicaltrials.gov/study/NCT07335562",
"title": "A Phase 3, Randomized, Open-label, Multicenter Study to Compare the Efficacy and Safety of BMS-986353, CD19-targeted NEX-T CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis (Breakfree-SSc)",
"has_exemption": false,
"start_date": "2027-02-03",
"completion_date": "2028-11-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Juno Therapeutics, Inc., a Bristol-Myers Squibb Company",
"sponsor_slug": "juno-therapeutics-inc-a-bristol-myers-squibb-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04626024",
"publication_url": "https://clinicaltrials.gov/study/NCT04626024",
"title": "Safety And Efficacy Of Tyrosine Kinase Inhibitor Cessation For Chronic Myeloid Leukemia Patients With Stable Molecular Response In A Real World Population",
"has_exemption": false,
"start_date": "2020-12-22",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor College of Medicine",
"sponsor_slug": "baylor-college-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06571383",
"publication_url": "https://clinicaltrials.gov/study/NCT06571383",
"title": "Weight Maintenance in Adolescents With Obesity; Long-Term Treatment With Semaglutide s.c.2.4 mg Once-weekly",
"has_exemption": false,
"start_date": "2024-09-17",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06847542",
"publication_url": "https://clinicaltrials.gov/study/NCT06847542",
"title": "A Phase IIIb, Multicenter, Single-arm Study Assessing the Effectiveness, Safety and Patient Reported Outcomes of a 36-week Refill Exchange Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration",
"has_exemption": false,
"start_date": "2025-11-27",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07092527",
"publication_url": "https://clinicaltrials.gov/study/NCT07092527",
"title": "Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version",
"has_exemption": false,
"start_date": "2025-12-05",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07214779",
"publication_url": "https://clinicaltrials.gov/study/NCT07214779",
"title": "A Phase 3, Randomized, Open-Label Study of INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression",
"has_exemption": false,
"start_date": "2025-12-09",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05490277",
"publication_url": "https://clinicaltrials.gov/study/NCT05490277",
"title": "Vibrotactile Coordinated Reset for the Treatment of Chronic Stroke",
"has_exemption": false,
"start_date": "2026-01-15",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07411599",
"publication_url": "https://clinicaltrials.gov/study/NCT07411599",
"title": "Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial (\"Chip-CRC Trial\")",
"has_exemption": false,
"start_date": "2026-04-20",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07499232",
"publication_url": "https://clinicaltrials.gov/study/NCT07499232",
"title": "A Phase 3b, Multicenter, Randomized, Open-Label, Active-Controlled Study to Compare the Efficacy and Safety of Guselkumab Versus Risankizumab in the Treatment of Participants With Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2026-04-21",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06097728",
"publication_url": "https://clinicaltrials.gov/study/NCT06097728",
"title": "A Phase III, Randomized, Open-Label, Multicenter, Global Study of Volrustomig (MEDI5752) in Combination With Carboplatin Plus Pemetrexed Versus Platinum Plus Pemetrexed or Nivolumab Plus Ipilimumab in Participants With Unresectable Pleural Mesothelioma (eVOLVE-Meso)",
"has_exemption": false,
"start_date": "2023-11-09",
"completion_date": "2028-11-16",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218809",
"publication_url": "https://clinicaltrials.gov/study/NCT07218809",
"title": "A Randomised, Open-label, Phase III Study of AZD5335 Versus Mirvetuximab Soravtansine in FRα-high and AZD5335 Versus Investigator's Choice Chemotherapy in FRα-low Expressing High-grade Platinum-resistant Epithelial Ovarian Cancer Patients (TREVI-OC-01)",
"has_exemption": false,
"start_date": "2025-12-29",
"completion_date": "2028-11-17",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07709546",
"publication_url": "https://clinicaltrials.gov/study/NCT07709546",
"title": "The Prophylactic Effect of Closed Incision Negative Pressure Therapy on Vascular Entry Site Complications Following ECMO Decannulation",
"has_exemption": false,
"start_date": "2026-07-13",
"completion_date": "2028-11-18",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Antonius Hospital",
"sponsor_slug": "st-antonius-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06858735",
"publication_url": "https://clinicaltrials.gov/study/NCT06858735",
"title": "HYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patients With Advanced Intrahepatic Cholangiocarcinoma",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2028-11-19",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07252050",
"publication_url": "https://clinicaltrials.gov/study/NCT07252050",
"title": "Ruxolitinib-Enhanced Conditioning for Pediatric and Young Adult Patients With Symptomatic Sickle Cell Disease Undergoing Haploidentical Hematopoietic Cell Transplantation",
"has_exemption": false,
"start_date": "2026-06-08",
"completion_date": "2028-11-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Arkansas Children's Hospital Research Institute",
"sponsor_slug": "arkansas-childrens-hospital-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06112379",
"publication_url": "https://clinicaltrials.gov/study/NCT06112379",
"title": "A Phase III, Open-label, Randomised Study of Neoadjuvant Datopotamab Deruxtecan (Dato-DXd) Plus Durvalumab Followed by Adjuvant Durvalumab With or Without Chemotherapy Versus Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab With or Without Chemotherapy for the Treatment of Adult Patients With Previously Untreated Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer (D926QC00001; TROPION-Breast04)",
"has_exemption": false,
"start_date": "2023-11-14",
"completion_date": "2028-11-20",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07430592",
"publication_url": "https://clinicaltrials.gov/study/NCT07430592",
"title": "A Phase 2B Trial of the Combination of SJ733 and Tafenoquine for Radical Cure of P. Vivax Malaria in Comparison to Chloroquine-Tafenoquine",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2028-11-20",
"has_results": false,
"results_due": false,
"sponsor_name": "R. Kiplin Guy",
"sponsor_slug": "r-kiplin-guy",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07775924",
"publication_url": "https://clinicaltrials.gov/study/NCT07775924",
"title": "A Phase IIb Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-range Study to Assess the Efficacy and Safety of GIA632 in Participants With Moderate to Severe Cutaneous Lichen Planus, Followed by an Extension Period",
"has_exemption": false,
"start_date": "2026-09-29",
"completion_date": "2028-11-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07011732",
"publication_url": "https://clinicaltrials.gov/study/NCT07011732",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-07-10",
"completion_date": "2028-11-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07257055",
"publication_url": "https://clinicaltrials.gov/study/NCT07257055",
"title": "Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2028-11-24",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07830329",
"publication_url": "https://clinicaltrials.gov/study/NCT07830329",
"title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group 52-Week Trial to Investigate the Efficacy and Safety of Olatorepatide, a GLP-1/GIP Receptor Agonist, in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or Obesity",
"has_exemption": false,
"start_date": "2026-10-30",
"completion_date": "2028-11-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06947993",
"publication_url": "https://clinicaltrials.gov/study/NCT06947993",
"title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase II Platform Study to Assess the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis",
"has_exemption": false,
"start_date": "2025-05-16",
"completion_date": "2028-11-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06184152",
"publication_url": "https://clinicaltrials.gov/study/NCT06184152",
"title": "Contrast Ultrasound vs. Abbreviated MRI for Detection of HCC in Patients With Indeterminate Liver Nodules",
"has_exemption": false,
"start_date": "2023-11-28",
"completion_date": "2028-11-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07321574",
"publication_url": "https://clinicaltrials.gov/study/NCT07321574",
"title": "An Open-Label, Multi-Cohort Phase IIb Clinical Study Evaluating the Efficacy and Safety of ABP1011T Tablets in Patients With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-12-30",
"completion_date": "2028-11-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Shanghai AB PharmaTech Ltd.",
"sponsor_slug": "shanghai-ab-pharmatech-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221669",
"publication_url": "https://clinicaltrials.gov/study/NCT07221669",
"title": "An Open-Label Study to Assess the Efficacy and Safety of Multiple Doses of Salanersen (BIIB115) Delivered Intrathecally to Treatment-Naïve, Presymptomatic Infants With Genetically Diagnosed Spinal Muscular Atrophy",
"has_exemption": false,
"start_date": "2026-04-28",
"completion_date": "2028-11-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Biogen",
"sponsor_slug": "biogen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06649110",
"publication_url": "https://clinicaltrials.gov/study/NCT06649110",
"title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of LTP001 in Healthy Adult Participants (Part A) and to Evaluate the Efficacy and Safety of LTP001 for the Treatment of Participants With Pulmonary Arterial Hypertension (Part B)",
"has_exemption": false,
"start_date": "2024-10-24",
"completion_date": "2028-11-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07024563",
"publication_url": "https://clinicaltrials.gov/study/NCT07024563",
"title": "A Phase 3, Open-Label, Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Ravulizumab in Pediatric Participants (2 to < 18 Years of Age) With Primary Immunoglobulin A Nephropathy (IgAN)",
"has_exemption": false,
"start_date": "2025-06-14",
"completion_date": "2028-11-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Alexion Pharmaceuticals, Inc.",
"sponsor_slug": "alexion-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00682318",
"publication_url": "https://clinicaltrials.gov/study/NCT00682318",
"title": "Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers: a Randomized Double-blinded Trial on the Modulation of the Eicosanoid and Isoprostane Pathways in Healthy Subjects by Omega-3 Polyunsaturated Fatty Acids and Red Wine.",
"has_exemption": false,
"start_date": "2008-05-31",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Carsten Skarke, MD",
"sponsor_slug": "carsten-skarke-md",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03301506",
"publication_url": "https://clinicaltrials.gov/study/NCT03301506",
"title": "ASSURE: An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)",
"has_exemption": false,
"start_date": "2017-12-12",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03833921",
"publication_url": "https://clinicaltrials.gov/study/NCT03833921",
"title": "Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity, PSA Decline and Genetic Variation in Proteins Involved in Androgen Metabolism in Metastatic Hormone Naive Prostate Cancer",
"has_exemption": false,
"start_date": "2019-05-23",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Martha Mims",
"sponsor_slug": "martha-mims",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04781972",
"publication_url": "https://clinicaltrials.gov/study/NCT04781972",
"title": "Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD",
"has_exemption": false,
"start_date": "2021-07-27",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05079841",
"publication_url": "https://clinicaltrials.gov/study/NCT05079841",
"title": "The Stimulation To Induce Mothers (STIM) Study: A Parallel Group Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2021-11-15",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05228145",
"publication_url": "https://clinicaltrials.gov/study/NCT05228145",
"title": "A Phase 1/2 Intracerebroventricular and Intravitreal Administration of NGN-101 for Treatment of Neuronal Ceroid Lipofuscinosis (NCL) Subtype 5 (CLN5) Disease",
"has_exemption": false,
"start_date": "2022-01-31",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurogene Inc.",
"sponsor_slug": "neurogene-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05076617",
"publication_url": "https://clinicaltrials.gov/study/NCT05076617",
"title": "An Open-Label, Multicenter, Outpatient Extension Study to Evaluate the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures",
"has_exemption": false,
"start_date": "2022-02-03",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05121376",
"publication_url": "https://clinicaltrials.gov/study/NCT05121376",
"title": "A Phase 1/2 Open-Label, Dose-Escalation Study to Determine the Safety Tolerability & Efficacy of BMN 331 an AAV Vector-Mediated Gene Transfer of Human SERPING1 Gene in Subjects With HAE Due to Human C1-INH Deficiency",
"has_exemption": false,
"start_date": "2022-02-15",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BioMarin Pharmaceutical",
"sponsor_slug": "biomarin-pharmaceutical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05281731",
"publication_url": "https://clinicaltrials.gov/study/NCT05281731",
"title": "Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma",
"has_exemption": false,
"start_date": "2022-04-18",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05194111",
"publication_url": "https://clinicaltrials.gov/study/NCT05194111",
"title": "Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan (Treat HF)",
"has_exemption": false,
"start_date": "2022-08-11",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05278208",
"publication_url": "https://clinicaltrials.gov/study/NCT05278208",
"title": "Phase I/II Study of Lutathera in Patients With Recurrent and/or Progressive High-Grade Central Nervous System Tumors and Meningiomas That Demonstrate Uptake on DOTATATE PET",
"has_exemption": false,
"start_date": "2022-11-21",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Nationwide Children's Hospital",
"sponsor_slug": "nationwide-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05421897",
"publication_url": "https://clinicaltrials.gov/study/NCT05421897",
"title": "RAPID Study: A Pilot Study for the Rapid Infusion of Dinutuximab",
"has_exemption": false,
"start_date": "2022-11-29",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Los Angeles",
"sponsor_slug": "childrens-hospital-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05669989",
"publication_url": "https://clinicaltrials.gov/study/NCT05669989",
"title": "International, Multi-center, Open-label, Treatment Extension Study in Patients With Multiple Myeloma Who Are Still Benefitting From Isatuximab-based Therapy Following Completion of a Phase 1, 2, or 3 Parental Study",
"has_exemption": false,
"start_date": "2023-04-05",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05796375",
"publication_url": "https://clinicaltrials.gov/study/NCT05796375",
"title": "Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance",
"has_exemption": false,
"start_date": "2023-11-17",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "White River Junction Veterans Affairs Medical Center",
"sponsor_slug": "white-river-junction-veterans-affairs-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06157528",
"publication_url": "https://clinicaltrials.gov/study/NCT06157528",
"title": "Diagnosis of Pelvic Endometriosis: a Preliminary Study on the Added Value of R2*MFGRE Sequence in MRI",
"has_exemption": false,
"start_date": "2023-12-20",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Zhenshen Ma",
"sponsor_slug": "zhenshen-ma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06169852",
"publication_url": "https://clinicaltrials.gov/study/NCT06169852",
"title": "Stimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD",
"has_exemption": false,
"start_date": "2024-01-12",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06075953",
"publication_url": "https://clinicaltrials.gov/study/NCT06075953",
"title": "DCIS: RECAST Trial -Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment: a Breast Cancer Prevention Pilot Study",
"has_exemption": false,
"start_date": "2024-02-17",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "QuantumLeap Healthcare Collaborative",
"sponsor_slug": "quantumleap-healthcare-collaborative",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05940324",
"publication_url": "https://clinicaltrials.gov/study/NCT05940324",
"title": "Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)",
"has_exemption": false,
"start_date": "2024-02-24",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06316297",
"publication_url": "https://clinicaltrials.gov/study/NCT06316297",
"title": "A Phase I/II, Randomized, Placebo-controlled, Multi-arm, Dose-finding Study to Evaluate the Safety, Efficacy and Immunogenicity of an Acne mRNA Vaccine Candidate in Adults With Moderate to Severe Acne 18 to 45 Years of Age",
"has_exemption": false,
"start_date": "2024-04-05",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi Pasteur, a Sanofi Company",
"sponsor_slug": "sanofi-pasteur-a-sanofi-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06295159",
"publication_url": "https://clinicaltrials.gov/study/NCT06295159",
"title": "Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma",
"has_exemption": false,
"start_date": "2024-05-17",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06284122",
"publication_url": "https://clinicaltrials.gov/study/NCT06284122",
"title": "A Phase III Randomized, Open-label, International, Multicenter Study Evaluating the Efficacy and Safety of Mosunetuzumab Plus Lenalidomide in Comparison to Anti-CD20 Monoclonal Antibody Plus Chemotherapy in Subjects With Previously Untreated FLIPI 2-5 Follicular Lymphoma",
"has_exemption": false,
"start_date": "2024-06-07",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The Lymphoma Academic Research Organisation",
"sponsor_slug": "the-lymphoma-academic-research-organisation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05869682",
"publication_url": "https://clinicaltrials.gov/study/NCT05869682",
"title": "Phase 2 Study of Bright White Light During Treatment With ADT Combination Therapy in Men With Advanced Prostate Cancer to PreServe PHysIcal and MeNtal HEalth (SHINE)",
"has_exemption": false,
"start_date": "2024-07-09",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06535607",
"publication_url": "https://clinicaltrials.gov/study/NCT06535607",
"title": "A Phase II, Multi-Center Study to Evaluate the Efficacy and Safety of Volrustomig as Monotherapy or in Combination With Anti-cancer Agents in Participants With Advanced/Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2024-08-22",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06467305",
"publication_url": "https://clinicaltrials.gov/study/NCT06467305",
"title": "Sensorimotor Basis of Speech Motor Learning and Retention",
"has_exemption": false,
"start_date": "2024-10-01",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06491823",
"publication_url": "https://clinicaltrials.gov/study/NCT06491823",
"title": "Sensorimotor Basis of Speech Motor Learning and Retention",
"has_exemption": false,
"start_date": "2024-10-01",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06467292",
"publication_url": "https://clinicaltrials.gov/study/NCT06467292",
"title": "Sensorimotor Basis of Speech Motor Learning and Retention",
"has_exemption": false,
"start_date": "2024-10-01",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06581432",
"publication_url": "https://clinicaltrials.gov/study/NCT06581432",
"title": "Beamion PANTUMOR-1: A Phase II, Multicentre, Multicohort, Open-label Trial to Evaluate the Efficacy and Safety of Oral Zongertinib (BI 1810631) for the Treatment of Selected HER2-mutated or Overexpressed/Amplified Solid Tumours",
"has_exemption": false,
"start_date": "2024-10-11",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06487221",
"publication_url": "https://clinicaltrials.gov/study/NCT06487221",
"title": "A Phase II Trial of Avutometinib in Combination With Defactinib in Metastatic Diffuse Gastric Cancer",
"has_exemption": false,
"start_date": "2024-10-28",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ryan H. Moy, MD, PhD",
"sponsor_slug": "ryan-h-moy-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06655896",
"publication_url": "https://clinicaltrials.gov/study/NCT06655896",
"title": "A Phase II, Multi-part, Randomized, Open-label, Assessor-blinded, Active-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel Versus Rituximab Treatment in Participants With Severe Refractory Diffuse Cutaneous Systemic Sclerosis",
"has_exemption": false,
"start_date": "2024-10-29",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06399679",
"publication_url": "https://clinicaltrials.gov/study/NCT06399679",
"title": "Rivastigmine to Prevent Recurrence of Antimuscarinic Delirium After Initial Control With Physostigmine (RIVA-AP): a Randomized, Placebo-controlled Trial",
"has_exemption": false,
"start_date": "2024-11-04",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06111313",
"publication_url": "https://clinicaltrials.gov/study/NCT06111313",
"title": "A Phase 2 Risk Adapted Parallel Randomized Trial of MRI-Guided Lattice Stereotactic Focal Radiotherapy of the Prostate With or Without Ultra-Short Term Androgen Deprivation Therapy-The Miami UAdapt Trial",
"has_exemption": false,
"start_date": "2024-11-06",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06703476",
"publication_url": "https://clinicaltrials.gov/study/NCT06703476",
"title": "A Clinically Integrated Randomized Clinical Trial (RCT) of Modifications to Radical Cystectomy and Postoperative Care",
"has_exemption": false,
"start_date": "2024-11-21",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06463457",
"publication_url": "https://clinicaltrials.gov/study/NCT06463457",
"title": "Comeback From Long coursE ADT With RElugolix and Darolutamide in Hormone-sensitive Prostate Cancer (CLEARED)",
"has_exemption": false,
"start_date": "2024-12-13",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Atish Choudhury, MD",
"sponsor_slug": "atish-choudhury-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06846541",
"publication_url": "https://clinicaltrials.gov/study/NCT06846541",
"title": "An Extension Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Long-term Safety, Efficacy, and Durability of Response to ESK-001",
"has_exemption": false,
"start_date": "2025-01-08",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Alumis Inc",
"sponsor_slug": "alumis-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06822738",
"publication_url": "https://clinicaltrials.gov/study/NCT06822738",
"title": "A Prospective, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Subjects With Glaucoma",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06829238",
"publication_url": "https://clinicaltrials.gov/study/NCT06829238",
"title": "Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use (MET-IH)",
"has_exemption": false,
"start_date": "2025-04-07",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07301177",
"publication_url": "https://clinicaltrials.gov/study/NCT07301177",
"title": "AtMS for Alleviating Posttraumatic Peripheral Neuropathic Pain (PTP-NP)",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Veterans Medical Research Foundation",
"sponsor_slug": "veterans-medical-research-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06271590",
"publication_url": "https://clinicaltrials.gov/study/NCT06271590",
"title": "The MAGICAL SV Trial - A Prospective, Multicenter, Randomized, Two-Arm, Single-blind Non Inferiority Trial to Evaluate the Safety and Efficacy of the MagicTouch™ Sirolimus-Coated Balloon in the Treatment of Small Vessels in Patients With Coronary Artery Disease.",
"has_exemption": false,
"start_date": "2025-05-20",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Concept Medical Inc.",
"sponsor_slug": "concept-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06973564",
"publication_url": "https://clinicaltrials.gov/study/NCT06973564",
"title": "A Phase 1/2a, Multicenter, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of JAB-23E73 Monotherapy and in Combination With Other Agents in Adult Patients With Advanced Solid Tumors With KRAS Alteration",
"has_exemption": false,
"start_date": "2025-05-29",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Jacobio Pharmaceuticals Co., Ltd.",
"sponsor_slug": "jacobio-pharmaceuticals-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07013110",
"publication_url": "https://clinicaltrials.gov/study/NCT07013110",
"title": "An Artificial Intelligence-powered Approach to Precision Immunotherapy of Human Arthritis - A Double-blind, Randomized, Placebo-controlled Clinical Trial",
"has_exemption": false,
"start_date": "2025-06-18",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Prof Salvatore Albani",
"sponsor_slug": "prof-salvatore-albani",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07124910",
"publication_url": "https://clinicaltrials.gov/study/NCT07124910",
"title": "Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure Versus a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Woolfson Eye Institute",
"sponsor_slug": "woolfson-eye-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07135167",
"publication_url": "https://clinicaltrials.gov/study/NCT07135167",
"title": "Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Woolfson Eye Institute",
"sponsor_slug": "woolfson-eye-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07047144",
"publication_url": "https://clinicaltrials.gov/study/NCT07047144",
"title": "A Phase 2, Double-Blind Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Apitegromab in Subjects <2 Years Old With Spinal Muscular Atrophy (SMA)",
"has_exemption": false,
"start_date": "2025-09-15",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Scholar Rock, Inc.",
"sponsor_slug": "scholar-rock-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07111520",
"publication_url": "https://clinicaltrials.gov/study/NCT07111520",
"title": "A Phase Ib/II, Multi-site, Open-label, Dose Finding Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of BNT326 in Combination With BNT327 in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2025-09-22",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222085",
"publication_url": "https://clinicaltrials.gov/study/NCT07222085",
"title": "Determining the Long-Term Stability of the Glide Control Strategy for Upper Limb Prostheses",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Infinite Biomedical Technologies",
"sponsor_slug": "infinite-biomedical-technologies",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213804",
"publication_url": "https://clinicaltrials.gov/study/NCT07213804",
"title": "FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) Versus Chemotherapy or Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer, and Sofetabart Mipitecan Plus Bevacizumab Versus Platinum-Based Chemotherapy Plus Bevacizumab in Platinum-Sensitive Ovarian Cancer.",
"has_exemption": false,
"start_date": "2025-10-22",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06793215",
"publication_url": "https://clinicaltrials.gov/study/NCT06793215",
"title": "A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Patients With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-10-24",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06659445",
"publication_url": "https://clinicaltrials.gov/study/NCT06659445",
"title": "A Phase 2 Multicenter, Randomized, Double-masked, Sham-controlled, Reference-arm Study to Evaluate Efficacy and Safety of ONL1204 in Patients With Geographic Atrophy (GA) Associated With Age-related Macular Degeneration (AMD)",
"has_exemption": false,
"start_date": "2025-10-28",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ONL Therapeutics",
"sponsor_slug": "onl-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07216742",
"publication_url": "https://clinicaltrials.gov/study/NCT07216742",
"title": "A Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy and Safety of a Human Menopausal Gonadotropin in the Development of Multiple Follicles, Pregnancy, and Cumulative Live Birth as Part of an Assisted Reproductive Technology (ART) Cycle.",
"has_exemption": false,
"start_date": "2025-11-01",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Granata Bio Corporation",
"sponsor_slug": "granata-bio-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07032792",
"publication_url": "https://clinicaltrials.gov/study/NCT07032792",
"title": "Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery",
"has_exemption": false,
"start_date": "2025-11-03",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwell Health",
"sponsor_slug": "northwell-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06455319",
"publication_url": "https://clinicaltrials.gov/study/NCT06455319",
"title": "Precision Administration of Anti-thymocyte Globulin With or Without Verapamil in Adolescents and Young Adults With Type 1 Diabetes",
"has_exemption": false,
"start_date": "2025-11-12",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07387978",
"publication_url": "https://clinicaltrials.gov/study/NCT07387978",
"title": "A Pilot Study to Describe the Effect of Photobiomodulation in Reducing the Severity and Incidence of Oral Mucositis in Oral Cancer Patients Undergoing Radiation Treatment",
"has_exemption": false,
"start_date": "2025-11-26",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Peter MacCallum Cancer Centre, Australia",
"sponsor_slug": "peter-maccallum-cancer-centre-australia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07117669",
"publication_url": "https://clinicaltrials.gov/study/NCT07117669",
"title": "A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation and Expansion Study of ENP-501 in Non-Peanut Allergic Participants and Participants With a Known Peanut Allergy",
"has_exemption": false,
"start_date": "2025-12-16",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "N-Fold, LLC",
"sponsor_slug": "n-fold-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07228247",
"publication_url": "https://clinicaltrials.gov/study/NCT07228247",
"title": "A Phase Ⅰ/Ⅱa Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HMPL-A251 in Participants With Advanced or Metastatic HER2-Expressing Solid Tumors",
"has_exemption": false,
"start_date": "2025-12-16",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hutchmed",
"sponsor_slug": "hutchmed",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06575075",
"publication_url": "https://clinicaltrials.gov/study/NCT06575075",
"title": "A Double-blind, Placebo-controlled Study to Determine the Safety and Feasibility of Two Doses of Intravenous (2R, 6R)-Hydroxynorketamine (RR-HNK) in Adults With Obsessive-Compulsive Disorder",
"has_exemption": false,
"start_date": "2026-01-23",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Carolyn Rodriguez",
"sponsor_slug": "carolyn-rodriguez",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07091279",
"publication_url": "https://clinicaltrials.gov/study/NCT07091279",
"title": "Randomized Controlled Trial of Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism",
"has_exemption": false,
"start_date": "2026-01-30",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Jeremy Veenstra-vanderweele",
"sponsor_slug": "jeremy-veenstra-vanderweele",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07424378",
"publication_url": "https://clinicaltrials.gov/study/NCT07424378",
"title": "Randomized Controlled Trial of Epoprostenol Versus Placebo in Addition to Standard Therapy for Severe Frostbite Injury",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06434064",
"publication_url": "https://clinicaltrials.gov/study/NCT06434064",
"title": "A Pilot, Single-Arm, Phase II Trial of Tamoxifen Plus Pegylated Liposomal Doxorubicin in Patients With Metastatic Triple Negative Breast Cancer",
"has_exemption": false,
"start_date": "2026-03-03",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227025",
"publication_url": "https://clinicaltrials.gov/study/NCT07227025",
"title": "A Phase 1/2 Study Evaluating the Safety and Efficacy of Amivantamab and Olomorasib Combination Therapy in Metastatic Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-03-03",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07344220",
"publication_url": "https://clinicaltrials.gov/study/NCT07344220",
"title": "Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye Conjugate",
"has_exemption": false,
"start_date": "2026-03-05",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoag Memorial Hospital Presbyterian",
"sponsor_slug": "hoag-memorial-hospital-presbyterian",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07407933",
"publication_url": "https://clinicaltrials.gov/study/NCT07407933",
"title": "A Phase Ib/II, Multicenter, Open-Label Study to Evaluate Safety, Efficacy, and Pharmacokinetics of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "MediLink Therapeutics (Suzhou) Co., Ltd.",
"sponsor_slug": "medilink-therapeutics-suzhou-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07107334",
"publication_url": "https://clinicaltrials.gov/study/NCT07107334",
"title": "A Pilot Study to Estimate Early Clinical Efficacy Signals of a Glucagon-like Peptide 1 Receptor Agonist (GLP-1RA) Administration in Conjunction With Levonorgestrel Intrauterine Device (LNG-IUD) in Obese Patients With Endometrioid Intraepithelial Neoplasia",
"has_exemption": false,
"start_date": "2026-04-07",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07133074",
"publication_url": "https://clinicaltrials.gov/study/NCT07133074",
"title": "Optimizing Antibiotic Selection in Hematologic Malignancy Patients With Reported Beta-lactam Allergy - Intervention",
"has_exemption": false,
"start_date": "2026-04-20",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Abramson Cancer Center at Penn Medicine",
"sponsor_slug": "abramson-cancer-center-at-penn-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07326566",
"publication_url": "https://clinicaltrials.gov/study/NCT07326566",
"title": "A Phase 2 Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Silevertinib, an Oral EGFR Inhibitor, in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma With Unmethylated MGMT Promoter and EGFRvIII",
"has_exemption": false,
"start_date": "2026-05-05",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Black Diamond Therapeutics, Inc.",
"sponsor_slug": "black-diamond-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07428746",
"publication_url": "https://clinicaltrials.gov/study/NCT07428746",
"title": "Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes",
"has_exemption": false,
"start_date": "2026-05-07",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07571135",
"publication_url": "https://clinicaltrials.gov/study/NCT07571135",
"title": "Letermovir Versus Valganciclovir for 90 Days in CMV Seropositive Kidney Transplant Recipients: Results of a Single-center Experience.",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Elisabeth Kincaide",
"sponsor_slug": "elisabeth-kincaide",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07673107",
"publication_url": "https://clinicaltrials.gov/study/NCT07673107",
"title": "A Phase 2b Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period to Evaluate the Efficacy and Safety of AGN-151607-DP (USAN: gemibotulinumtoxinA) for the Treatment of Upper Limb Essential Tremor in Adults",
"has_exemption": false,
"start_date": "2026-06-18",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06210854",
"publication_url": "https://clinicaltrials.gov/study/NCT06210854",
"title": "Double-Blind Randomized Phase II Clinical Trial Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+ <CIN2",
"has_exemption": false,
"start_date": "2026-06-25",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06382649",
"publication_url": "https://clinicaltrials.gov/study/NCT06382649",
"title": "Rivastigmine for Antimuscarinic Delirium: a Randomized, Placebo-controlled Trial",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07527299",
"publication_url": "https://clinicaltrials.gov/study/NCT07527299",
"title": "Assessment of the Safety and Effectiveness of the VARIPULSE™ Catheter System in the Treatment of Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein (With or Without Posterior Wall Isolation) and Superior Vena Cava Isolation: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2026-08-26",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Biosense Webster, Inc.",
"sponsor_slug": "biosense-webster-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07650201",
"publication_url": "https://clinicaltrials.gov/study/NCT07650201",
"title": "A Prospective, Multicenter, Open-label, Single-arm Clinical Trial to Investigate the Safety and Effectiveness of the KI-362-US1 (YP2.2VM) IOL for Correction of Aphakia Following Cataract Extraction",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Kowa Research Institute, Inc.",
"sponsor_slug": "kowa-research-institute-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07393555",
"publication_url": "https://clinicaltrials.gov/study/NCT07393555",
"title": "A Randomized Phase II Study of Sacituzumab Govitecan Alone, Ivonescimab Alone, or Sacituzumab Govitecan and Ivonescimab in Participants With Previously-Treated Actionable Genomic Alteration Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Sub-Study)",
"has_exemption": false,
"start_date": "2026-09-22",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07705607",
"publication_url": "https://clinicaltrials.gov/study/NCT07705607",
"title": "A Randomized, Double-Masked, Multicenter, 3-Arm, Pivotal Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal (IVT) MK-8748 Compared With Aflibercept (2 mg) in Participants With Diabetic Macular Edema (DME)",
"has_exemption": false,
"start_date": "2026-09-25",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07552558",
"publication_url": "https://clinicaltrials.gov/study/NCT07552558",
"title": "Phase I/II Trial of Neoadjuvant Combination of Ficerafusp Alfa, Pembrolizumab, and SBRT for Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07570654",
"publication_url": "https://clinicaltrials.gov/study/NCT07570654",
"title": "A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "COMPASS Pathways",
"sponsor_slug": "compass-pathways",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07748403",
"publication_url": "https://clinicaltrials.gov/study/NCT07748403",
"title": "A Phase 1/2 Clinical Study to Evaluate Safety, Tolerability, Biological Activity, and Initial Efficacy of Prime Editing (PM577a) for the Treatment of Wilson Disease (WD) in Adult and Adolescent Participants With at Least One Allele Harboring the p.H1069Q Mutation in ATP7B",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Prime Medicine, Inc.",
"sponsor_slug": "prime-medicine-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07827573",
"publication_url": "https://clinicaltrials.gov/study/NCT07827573",
"title": "A Phase IIIb, Single-arm, Open-Label, Multicenter Study Evaluating the Treatment Adherence, Tolerability, and Patient-Reported Outcomes of Giredestrant in Patients With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer",
"has_exemption": false,
"start_date": "2026-10-30",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06458907",
"publication_url": "https://clinicaltrials.gov/study/NCT06458907",
"title": "A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "P+F Products + Features USA Inc.",
"sponsor_slug": "pf-products-features-usa-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07814417",
"publication_url": "https://clinicaltrials.gov/study/NCT07814417",
"title": "A Phase 2, Open-Label Study to Evaluate the Safety and Efficacy of Olomorasib in Combination With Cetuximab and mFOLFOX6 in Participants With KRAS G12C-Mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07831798",
"publication_url": "https://clinicaltrials.gov/study/NCT07831798",
"title": "A Phase 1/2, First-in-Human, Dose Escalation and Expansion Study to Evaluate the Safety, Tolerability, and Efficacy of VV-14300 (Adeno-associated Virus Vector-mediated Glucokinase) in Adults With Long-Standing Type 1 Diabetes and Suboptimal Glycemic Control Using an Automated Insulin Delivery (AID) System",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Kriya Therapeutics, Inc.",
"sponsor_slug": "kriya-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06820723",
"publication_url": "https://clinicaltrials.gov/study/NCT06820723",
"title": "A Randomized, Double-Blind, Placebo-Controlled Mechanistic Study to Assess a Single Oral Dose of CYB003 in Participants With Major Depressive Disorder (MDD) and Moderate to Severe Anxiety",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05669352",
"publication_url": "https://clinicaltrials.gov/study/NCT05669352",
"title": "MC250710 A Phase 1/2 Study of Oral IRAK-4 Inhibitor CA-4948 in Combination With Pembrolizumab and Stereotactic Radiosurgery in Patients With Melanoma Brain Metastases",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07581197",
"publication_url": "https://clinicaltrials.gov/study/NCT07581197",
"title": "A Phase 1/2 Dose Escalation Study to Evaluate the Safety and Efficacy of SR-02 Pancreatic Endocrine Cell Clusters Implanted in the Omentum of Adults With Type 1 Diabetes (SUGR)",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Seraxis",
"sponsor_slug": "seraxis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07750574",
"publication_url": "https://clinicaltrials.gov/study/NCT07750574",
"title": "A Randomized, Phase 2 Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Oral Flonoltinib Maleate in Patients With JAK Inhibitor Treatment-Naïve or Resistant Myelofibrosis",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Chengdu Zenitar Biomedical Technology Co., Ltd",
"sponsor_slug": "chengdu-zenitar-biomedical-technology-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07791446",
"publication_url": "https://clinicaltrials.gov/study/NCT07791446",
"title": "Pressure-Enabled Selective SIR-Sphere Uptake for Radiation Efficacy (PRESSURE): A Prospective Randomized Clinical Trial of End Hole vs. Pressure-Modulated Delivery of Y-90 Resin Microspheres to Liver Metastases.",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07843420",
"publication_url": "https://clinicaltrials.gov/study/NCT07843420",
"title": "Nemolizumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus: An Open-Label, Single-Arm, Exploratory Study",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07880743",
"publication_url": "https://clinicaltrials.gov/study/NCT07880743",
"title": "Extended Post-Operative Oral Tranexamic Acid Dosing After ACL Reconstruction: A Multicenter Randomized Controlled Trial (SM25091)",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dave Bernholt",
"sponsor_slug": "dave-bernholt",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07579351",
"publication_url": "https://clinicaltrials.gov/study/NCT07579351",
"title": "Corticosteroid Lumbar Epidural Analgesia for Radicular Pain (C.L.E.A.R) 2 - A Randomized, Double-blind, Active Comparator and Placebo-controlled, Multicenter, Safety and Efficacy Trial of SP-102",
"has_exemption": false,
"start_date": "2027-02-28",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Semnur Pharmaceuticals, Inc.",
"sponsor_slug": "semnur-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03217110",
"publication_url": "https://clinicaltrials.gov/study/NCT03217110",
"title": "Cerebellar Transcranial Magnetic Stimulation and Cognitive Control",
"has_exemption": false,
"start_date": "2017-11-30",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Krystal Parker, PhD",
"sponsor_slug": "krystal-parker-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04303117",
"publication_url": "https://clinicaltrials.gov/study/NCT04303117",
"title": "Phase I/II Study of PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma",
"has_exemption": false,
"start_date": "2020-07-13",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04588077",
"publication_url": "https://clinicaltrials.gov/study/NCT04588077",
"title": "Comparison the Seroconversion Rate Between Two-dose and Three-dose Regimens of Heplisav B Among Patients With Cirrhosis, a Randomized-control Prospective Study.",
"has_exemption": false,
"start_date": "2020-09-14",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mercy Medical Center",
"sponsor_slug": "mercy-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04825522",
"publication_url": "https://clinicaltrials.gov/study/NCT04825522",
"title": "The Effect of Intrawound Vancomycin Powder in Spine Surgery: A Prospective Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2022-03-27",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Windsor-Essex Compassionate Care Community",
"sponsor_slug": "windsor-essex-compassionate-care-community",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05517655",
"publication_url": "https://clinicaltrials.gov/study/NCT05517655",
"title": "BEGIN Novel ImagiNG Biomarkers",
"has_exemption": false,
"start_date": "2022-05-01",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05437705",
"publication_url": "https://clinicaltrials.gov/study/NCT05437705",
"title": "Decoding and Modulating Affective Brain States",
"has_exemption": false,
"start_date": "2023-02-21",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05303519",
"publication_url": "https://clinicaltrials.gov/study/NCT05303519",
"title": "A Phase 3, Multicenter, Clinical Study to Evaluate the Efficacy and Safety of Safusidenib Erbumine in Participants With Isocitrate Dehydrogenase 1 (IDH1)-Mutant Glioma",
"has_exemption": false,
"start_date": "2023-06-05",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Nuvation Bio, Inc.",
"sponsor_slug": "nuvation-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04969315",
"publication_url": "https://clinicaltrials.gov/study/NCT04969315",
"title": "A Phase 1/1b, Open-Label, First-in-Human Multicenter Study to Assess the Safety, Tolerability, Preliminary Efficacy, Pharmacokinetics, and Pharmacodynamics of Oral TT-10 (an Adenosine 2A Receptor Antagonist), and TT-4 Diacid (an Adenosine 2B Receptor Antagonist), as Single Agents and in Combination in Participants With Advanced Selected Solid Tumors",
"has_exemption": false,
"start_date": "2023-06-23",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Portage Biotech",
"sponsor_slug": "portage-biotech",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06082947",
"publication_url": "https://clinicaltrials.gov/study/NCT06082947",
"title": "αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT) for Children and Young Adults With Hematologic Malignancies",
"has_exemption": false,
"start_date": "2023-12-18",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Nationwide Children's Hospital",
"sponsor_slug": "nationwide-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06168942",
"publication_url": "https://clinicaltrials.gov/study/NCT06168942",
"title": "LAM202403: Laminar Left Atrial Appendage Elimination (LAAX) Pivotal IDE Study",
"has_exemption": false,
"start_date": "2024-02-19",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jaguar LAA, Inc.",
"sponsor_slug": "jaguar-laa-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06312813",
"publication_url": "https://clinicaltrials.gov/study/NCT06312813",
"title": "Pilot Studies Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea",
"has_exemption": false,
"start_date": "2024-02-27",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Wright State University",
"sponsor_slug": "wright-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06030622",
"publication_url": "https://clinicaltrials.gov/study/NCT06030622",
"title": "Phase 2A Pilot Trial of Metformin, Digoxin, Simvastatin (C3) in Combination With Gemcitabine in Subjects With Recurrent / Refractory Metastatic Advanced Pancreatic Cancer",
"has_exemption": false,
"start_date": "2024-04-17",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "State University of New York - Downstate Medical Center",
"sponsor_slug": "state-university-of-new-york-downstate-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06229912",
"publication_url": "https://clinicaltrials.gov/study/NCT06229912",
"title": "A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes",
"has_exemption": false,
"start_date": "2024-06-04",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06150417",
"publication_url": "https://clinicaltrials.gov/study/NCT06150417",
"title": "Metastasis-directed Radiotherapy (MDRT) for Men With De-novo Oligometastatic Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)",
"has_exemption": false,
"start_date": "2024-07-01",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Case Comprehensive Cancer Center",
"sponsor_slug": "case-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06282575",
"publication_url": "https://clinicaltrials.gov/study/NCT06282575",
"title": "An Open-label Randomized Trial of the Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy Alone for Advanced HER2-positive Biliary Tract Cancer",
"has_exemption": false,
"start_date": "2024-07-19",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jazz Pharmaceuticals",
"sponsor_slug": "jazz-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06496256",
"publication_url": "https://clinicaltrials.gov/study/NCT06496256",
"title": "Randomized Trial of Barrigel® to Increase Distance Between the Rectum and Prostate Bed to Decrease Rectal Dose in Patients Receiving Moderately Hypofractionated Radiation Therapy Who Have Had Recurrence of Prostate Cancer After Prostatectomy",
"has_exemption": false,
"start_date": "2024-10-31",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Palette Life Sciences, Inc.",
"sponsor_slug": "palette-life-sciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06493370",
"publication_url": "https://clinicaltrials.gov/study/NCT06493370",
"title": "Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative With Evident Efficacy in Patients With Muscle Invasive Bladder Cancer",
"has_exemption": false,
"start_date": "2025-01-16",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Kansas Medical Center",
"sponsor_slug": "university-of-kansas-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06216535",
"publication_url": "https://clinicaltrials.gov/study/NCT06216535",
"title": "Escitalopram in Asthma Patients With Frequent Exacerbation",
"has_exemption": false,
"start_date": "2025-05-19",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07258446",
"publication_url": "https://clinicaltrials.gov/study/NCT07258446",
"title": "PRAME (Preferentially Expressed Antigen in Melanoma) Immunohistochemistry Guided Slow-Mohs Micrographic Surgery of Malignant Melanoma: A Pragmatic Clinical Trial",
"has_exemption": false,
"start_date": "2025-10-24",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Davis",
"sponsor_slug": "university-of-california-davis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06419439",
"publication_url": "https://clinicaltrials.gov/study/NCT06419439",
"title": "Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression",
"has_exemption": false,
"start_date": "2025-12-03",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07280169",
"publication_url": "https://clinicaltrials.gov/study/NCT07280169",
"title": "Identifying Non-Union Rates Using Carbo-fix Lateral Plate Devices and Standard Plate-Nail Construct in Distal Femur Fractures",
"has_exemption": false,
"start_date": "2026-01-29",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Missouri-Columbia",
"sponsor_slug": "university-of-missouri-columbia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07237048",
"publication_url": "https://clinicaltrials.gov/study/NCT07237048",
"title": "Effect of Oral Minocycline in Patients With Acute Stroke - a Randomized, Open Label, Prospective Trial",
"has_exemption": false,
"start_date": "2026-02-02",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Joyce Chen",
"sponsor_slug": "joyce-chen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07199192",
"publication_url": "https://clinicaltrials.gov/study/NCT07199192",
"title": "A Multicenter, Randomized, Controlled Trial to Evaluate the Effectiveness and Safety of Systemic Corticosteroid Treatment for Hospitalized Patients With Severe Acute Respiratory Infection and Hypoxemia (STRIVE 003)",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07017829",
"publication_url": "https://clinicaltrials.gov/study/NCT07017829",
"title": "A Phase II Trial of GT103 in Combination With Pembrolizumab in STK11 Mutant Non-Small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07463521",
"publication_url": "https://clinicaltrials.gov/study/NCT07463521",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis",
"has_exemption": false,
"start_date": "2026-05-27",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07095894",
"publication_url": "https://clinicaltrials.gov/study/NCT07095894",
"title": "A Randomized Placebo-controlled Trial of Spectacles With Highly Aspherical Lenslet Target (H.A.L.T.) MAX Technology or 0.05% Atropine to Slow Progression of Myopia in Children",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jaeb Center for Health Research",
"sponsor_slug": "jaeb-center-for-health-research",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07535489",
"publication_url": "https://clinicaltrials.gov/study/NCT07535489",
"title": "A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of IPG11406 Tablets in Adult Patients With Moderately to Severely Active Ulcerative Colitis",
"has_exemption": false,
"start_date": "2026-07-07",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Nanjing Immunophage Biotech Co., Ltd",
"sponsor_slug": "nanjing-immunophage-biotech-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07228195",
"publication_url": "https://clinicaltrials.gov/study/NCT07228195",
"title": "SGLT2i Therapy in Islet Transplantation (SIT)",
"has_exemption": false,
"start_date": "2026-07-21",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07686068",
"publication_url": "https://clinicaltrials.gov/study/NCT07686068",
"title": "Phase 1/2a Open-Label Clinical Trial Evaluating VBC106, an FRα- and MSLN-Directed Bispecific Antibody Drug Conjugate, in Participants With Advanced Malignant Solid Tumors",
"has_exemption": false,
"start_date": "2026-08-18",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VelaVigo Bio Inc",
"sponsor_slug": "velavigo-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07741890",
"publication_url": "https://clinicaltrials.gov/study/NCT07741890",
"title": "aDAPt-ANOCA: Dapagliflozin for the Treatment of Angina With Non-Obstructive Coronary Artery Disease (ANOCA)",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The Christ Hospital",
"sponsor_slug": "the-christ-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07296770",
"publication_url": "https://clinicaltrials.gov/study/NCT07296770",
"title": "An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06965504",
"publication_url": "https://clinicaltrials.gov/study/NCT06965504",
"title": "Initiation and Titration of Guideline Directed Medical Therapy in Heart Failure Cardiogenic Shock With Impella 5.5 for Cardiac Recovery: INTeGRATE",
"has_exemption": false,
"start_date": "2026-10-02",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Abiomed Inc.",
"sponsor_slug": "abiomed-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07502339",
"publication_url": "https://clinicaltrials.gov/study/NCT07502339",
"title": "An Open-Label, Investigator-Initiated Study Evaluating the Use of Upadacitinib in Patients Hospitalized With Acute Severe Ulcerative Colitis",
"has_exemption": false,
"start_date": "2026-10-15",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03787290",
"publication_url": "https://clinicaltrials.gov/study/NCT03787290",
"title": "Examining Immune-Based Mechanisms of Action for Mild-Intensity Whole Body Hyperthermia (WBH) in the Treatment of Major Depressive Disorder",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07274787",
"publication_url": "https://clinicaltrials.gov/study/NCT07274787",
"title": "An Open Label, Prospective, Pilot Study To Evaluate The Safety And Effectiveness Of The NaviFUS System In Conjunction With A Standard Treatment Regimen Of Bevacizumab (BEV) In Patients With Recurrent Glioblastoma",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Cincinnati",
"sponsor_slug": "university-of-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07734077",
"publication_url": "https://clinicaltrials.gov/study/NCT07734077",
"title": "Phase Ib/II Study Of Revumenib As Monotherapy Or In Combination With Jak Inhibitors In Patients With Myelofibrosis",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "John Mascarenhas",
"sponsor_slug": "john-mascarenhas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07804368",
"publication_url": "https://clinicaltrials.gov/study/NCT07804368",
"title": "Platform Trial for Salvage Consolidation Therapy in Dimorphic Fungi",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07815574",
"publication_url": "https://clinicaltrials.gov/study/NCT07815574",
"title": "A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Adaptive Study of iSCIB1+ in Combination With Ipilimumab and Nivolumab as First-Line Treatment for Advanced Unresectable Melanoma",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Scancell Ltd",
"sponsor_slug": "scancell-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07832227",
"publication_url": "https://clinicaltrials.gov/study/NCT07832227",
"title": "A Phase II Trial of Imlunestrant/Abemaciclib/Selinexor in Low Grade Serous Ovarian Cancer and in Endometrioid Endometrial Cancer",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07878689",
"publication_url": "https://clinicaltrials.gov/study/NCT07878689",
"title": "A Phase 1/2 Study of Tegavivint Plus Zanzalintinib in Patients With Advanced Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2028-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06634589",
"publication_url": "https://clinicaltrials.gov/study/NCT06634589",
"title": "A Phase 1b/2, Open-Label, Master Protocol Study of BTK-Degrader BGB-16673 in Combination With Other Agents in Patients With Relapsed or Refractory B-Cell Malignancies",
"has_exemption": false,
"start_date": "2024-11-27",
"completion_date": "2028-12-02",
"has_results": false,
"results_due": false,
"sponsor_name": "BeOne Medicines",
"sponsor_slug": "beone-medicines",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05205174",
"publication_url": "https://clinicaltrials.gov/study/NCT05205174",
"title": "Depth Electrode Detection of Cortical Spreading Depolarization After Traumatic Brain Injury",
"has_exemption": false,
"start_date": "2025-04-03",
"completion_date": "2028-12-03",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06130553",
"publication_url": "https://clinicaltrials.gov/study/NCT06130553",
"title": "PRIMROSE: A Modular Phase I/IIa, Multi-centre, Dose Escalation, and Expansion Study of AZD3470, a MTA Cooperative PRMT5 Inhibitor, as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced/Metastatic Solid Tumors That Are MTAP Deficient",
"has_exemption": false,
"start_date": "2024-01-18",
"completion_date": "2028-12-04",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07540988",
"publication_url": "https://clinicaltrials.gov/study/NCT07540988",
"title": "A Double-blind, Randomized, Placebo-controlled Trial Investigating the Efficacy and Safety of Nerandomilast Over at Least 52 Weeks in Patients With Fibrosing Interstitial Lung Disease at Risk for Disease Progression (FIBRONEER-ACT)",
"has_exemption": false,
"start_date": "2026-09-17",
"completion_date": "2028-12-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05904080",
"publication_url": "https://clinicaltrials.gov/study/NCT05904080",
"title": "Randomized Phase 2 Study of Nivolumab and Ipilimumab With or Without Cabozantinib in Patients With Advanced Nasopharyngeal Carcinoma That Have Progressed After Platinum Treatment and Immunotherapy",
"has_exemption": false,
"start_date": "2024-02-19",
"completion_date": "2028-12-06",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07438496",
"publication_url": "https://clinicaltrials.gov/study/NCT07438496",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus",
"has_exemption": false,
"start_date": "2026-03-05",
"completion_date": "2028-12-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07759128",
"publication_url": "https://clinicaltrials.gov/study/NCT07759128",
"title": "A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicenter Trial to Compare the Efficacy and Safety of Fixed Doses of SEP-363856 to Placebo in the Treatment of Adults With Generalized Anxiety Disorder",
"has_exemption": false,
"start_date": "2026-07-28",
"completion_date": "2028-12-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Otsuka Pharmaceutical Development & Commercialization, Inc.",
"sponsor_slug": "otsuka-pharmaceutical-development-commercialization-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07569081",
"publication_url": "https://clinicaltrials.gov/study/NCT07569081",
"title": "A Randomized Phase 2/3, Double-blind, Placebo Controlled Adaptive Study Evaluating the Efficacy and Safety of Momelotinib in Participants With VEXAS Syndrome",
"has_exemption": false,
"start_date": "2026-08-05",
"completion_date": "2028-12-06",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218029",
"publication_url": "https://clinicaltrials.gov/study/NCT07218029",
"title": "An Open-label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH (MK-7962-038)",
"has_exemption": false,
"start_date": "2021-05-12",
"completion_date": "2028-12-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06596694",
"publication_url": "https://clinicaltrials.gov/study/NCT06596694",
"title": "A Phase 1/2 Study to Evaluate the Safety and Efficacy of Patritumab Deruxtecan in Gastrointestinal Cancers",
"has_exemption": false,
"start_date": "2024-11-03",
"completion_date": "2028-12-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06784752",
"publication_url": "https://clinicaltrials.gov/study/NCT06784752",
"title": "A Phase III Multi-center, Randomized, Open-label Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients Newly Diagnosed With Grade 1 and Grade 2 (Ki-67 <10%) Advanced GEP-NET With High Disease Burden (NETTER-3)",
"has_exemption": false,
"start_date": "2025-05-30",
"completion_date": "2028-12-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06093126",
"publication_url": "https://clinicaltrials.gov/study/NCT06093126",
"title": "Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial",
"has_exemption": false,
"start_date": "2023-12-11",
"completion_date": "2028-12-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Nova Scotia Health Authority",
"sponsor_slug": "nova-scotia-health-authority",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07282665",
"publication_url": "https://clinicaltrials.gov/study/NCT07282665",
"title": "A PHASE 3, PLACEBO-CONTROLLED, DOUBLE-BLINDED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF A CLOSTRIDIOIDES DIFFICILE VACCINE IN ADULTS 65 YEARS OF AGE AND OLDER",
"has_exemption": false,
"start_date": "2025-12-10",
"completion_date": "2028-12-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07646821",
"publication_url": "https://clinicaltrials.gov/study/NCT07646821",
"title": "A Phase 1b/2 Study of Ropeginterferon Alfa-2b Added to Azacitidine in MDS/AML With TP53 Mutations",
"has_exemption": false,
"start_date": "2026-10-27",
"completion_date": "2028-12-11",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07258511",
"publication_url": "https://clinicaltrials.gov/study/NCT07258511",
"title": "A Phase 3 Randomized Study Comparing JNJ-79635322 and an Anti-BCMAxCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy Including a PI, an IMiD, and an Anti CD38 Antibody",
"has_exemption": false,
"start_date": "2026-02-04",
"completion_date": "2028-12-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07400107",
"publication_url": "https://clinicaltrials.gov/study/NCT07400107",
"title": "Efficacy and Safety of NNC0487-0111 s.c. Once-weekly Compared to Semaglutide s.c. Once-weekly in Participants With Overweight or Obesity, and Type 2 Diabetes (AMAZE 8)",
"has_exemption": false,
"start_date": "2026-05-20",
"completion_date": "2028-12-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07680946",
"publication_url": "https://clinicaltrials.gov/study/NCT07680946",
"title": "Evaluating Safety and Efficacy of Ublituximab in Participants With Schizophrenia",
"has_exemption": false,
"start_date": "2026-07-27",
"completion_date": "2028-12-12",
"has_results": false,
"results_due": false,
"sponsor_name": "TG Therapeutics, Inc.",
"sponsor_slug": "tg-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06952660",
"publication_url": "https://clinicaltrials.gov/study/NCT06952660",
"title": "A PROSPECTIVE LOW-INTERVENTIONAL PHASE 4 SINGLE ARM STUDY OF OCULAR ASSESSMENTS IN PATIENTS TREATED WITH TIVDAK® IN RECURRENT OR METASTATIC CERVICAL CANCER",
"has_exemption": false,
"start_date": "2025-05-07",
"completion_date": "2028-12-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06959095",
"publication_url": "https://clinicaltrials.gov/study/NCT06959095",
"title": "A Randomized, Double-Blind, Placebo- Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Depemokimab In Adult Participants With COPD With Type 2 Inflammation",
"has_exemption": false,
"start_date": "2025-06-20",
"completion_date": "2028-12-13",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06961214",
"publication_url": "https://clinicaltrials.gov/study/NCT06961214",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Depemokimab in Adult Participants With COPD With Type 2 Inflammation",
"has_exemption": false,
"start_date": "2025-06-23",
"completion_date": "2028-12-13",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07801495",
"publication_url": "https://clinicaltrials.gov/study/NCT07801495",
"title": "A Randomized, Double-blind, Placebo-controlled, Multicenter Phase 2a/b Study Assessing the Efficacy, Safety and Tolerability of DDY391 in Participants With Active Moderate to Severe Psoriatic Arthritis",
"has_exemption": false,
"start_date": "2026-10-14",
"completion_date": "2028-12-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07386002",
"publication_url": "https://clinicaltrials.gov/study/NCT07386002",
"title": "A Phase II, Open-Label, Multicenter Study With a Safety Run-In to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of MT027 Administrated Intracerebroventricularly in Patients With Recurrent or Progressive Glioblastoma (WHO Grade 4)",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2028-12-13",
"has_results": false,
"results_due": false,
"sponsor_name": "T-MAXIMUM Pharmaceutical Inc",
"sponsor_slug": "t-maximum-pharmaceutical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07513181",
"publication_url": "https://clinicaltrials.gov/study/NCT07513181",
"title": "A Phase 2b, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Clinical Study to Evaluate the Efficacy and Safety of ATH-063 Induction Therapy in Patients With Biologic Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2028-12-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Athos Therapeutics Inc",
"sponsor_slug": "athos-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06662786",
"publication_url": "https://clinicaltrials.gov/study/NCT06662786",
"title": "A Randomized, Open-label Phase 3 Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer",
"has_exemption": false,
"start_date": "2024-10-18",
"completion_date": "2028-12-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06708949",
"publication_url": "https://clinicaltrials.gov/study/NCT06708949",
"title": "A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)",
"has_exemption": false,
"start_date": "2025-03-20",
"completion_date": "2028-12-15",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07100080",
"publication_url": "https://clinicaltrials.gov/study/NCT07100080",
"title": "IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy",
"has_exemption": false,
"start_date": "2025-11-05",
"completion_date": "2028-12-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07281716",
"publication_url": "https://clinicaltrials.gov/study/NCT07281716",
"title": "A Phase 1b/2 Study of Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer (CRC)",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2028-12-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Dan Feng",
"sponsor_slug": "dan-feng",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07293754",
"publication_url": "https://clinicaltrials.gov/study/NCT07293754",
"title": "A Phase 1/2 Trial of RPTR-1-201, a T Cell Receptor Bispecific Therapy, in Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-12-12",
"completion_date": "2028-12-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Repertoire Immune Medicines",
"sponsor_slug": "repertoire-immune-medicines",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07282587",
"publication_url": "https://clinicaltrials.gov/study/NCT07282587",
"title": "A Phase 2 Study of ONC206 in Advanced Pheochromocytoma and Paraganglioma",
"has_exemption": false,
"start_date": "2026-01-02",
"completion_date": "2028-12-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Jazz Pharmaceuticals",
"sponsor_slug": "jazz-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07840365",
"publication_url": "https://clinicaltrials.gov/study/NCT07840365",
"title": "Optimal Anti-Thrombotic Management Following Percutaneous Left Atrial Appendage Occlusion (INTEGRAL)",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2028-12-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Texas Cardiac Arrhythmia Research Foundation",
"sponsor_slug": "texas-cardiac-arrhythmia-research-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07781644",
"publication_url": "https://clinicaltrials.gov/study/NCT07781644",
"title": "A Phase II, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of RO7568282 in Participants With Early-stage Parkinson's Disease",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-12-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07816289",
"publication_url": "https://clinicaltrials.gov/study/NCT07816289",
"title": "A Phase 3, Randomized, Double-masked, Multicenter, Active Comparator-controlled Trial to Investigate the Efficacy and Safety of Monthly Intravitreal OLN324 in Adult Participants With Neovascular (Wet) Age-related Macular Degeneration (nAMD)",
"has_exemption": false,
"start_date": "2026-10-15",
"completion_date": "2028-12-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Ollin Biosciences, Inc.",
"sponsor_slug": "ollin-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07816315",
"publication_url": "https://clinicaltrials.gov/study/NCT07816315",
"title": "A Phase 3, Randomized, Double-masked, Multicenter, Active Comparator-controlled Trial to Investigate the Efficacy and Safety of Intravitreal OLN324 in Adult Participants With Neovascular (Wet) Age-related Macular Degeneration (nAMD)",
"has_exemption": false,
"start_date": "2026-10-15",
"completion_date": "2028-12-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Ollin Biosciences, Inc.",
"sponsor_slug": "ollin-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07842016",
"publication_url": "https://clinicaltrials.gov/study/NCT07842016",
"title": "A Phase 3, Randomized, Double-masked, Multicenter, Active Comparator-controlled Trial to Investigate the Efficacy and Safety of Intravitreal OLN324 in Adult Participants With Diabetic Macular Edema (DME) (GOBI)",
"has_exemption": false,
"start_date": "2026-10-15",
"completion_date": "2028-12-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Ollin Biosciences, Inc.",
"sponsor_slug": "ollin-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07841899",
"publication_url": "https://clinicaltrials.gov/study/NCT07841899",
"title": "A Phase 3, Randomized, Double-masked, Multicenter, Active Comparator-controlled Trial to Investigate the Efficacy and Safety of Intravitreal OLN324 in Adult Participants With Diabetic Macular Edema (DME) (ATACAMA)",
"has_exemption": false,
"start_date": "2026-10-15",
"completion_date": "2028-12-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Ollin Biosciences, Inc.",
"sponsor_slug": "ollin-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07852923",
"publication_url": "https://clinicaltrials.gov/study/NCT07852923",
"title": "Modulating Ventral Striatal Activity and Connectivity With Transcranial Focused Ultrasound as a Putative Novel Intervention for Cocaine Use Disorder",
"has_exemption": false,
"start_date": "2026-12-15",
"completion_date": "2028-12-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Mary Phillips, MD MD (Cantab)",
"sponsor_slug": "mary-phillips-md-md-cantab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06572423",
"publication_url": "https://clinicaltrials.gov/study/NCT06572423",
"title": "Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatment (PULS-Pal)",
"has_exemption": false,
"start_date": "2024-10-25",
"completion_date": "2028-12-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07595874",
"publication_url": "https://clinicaltrials.gov/study/NCT07595874",
"title": "A Phase II Novel Exploratory Study to Test Neoadjuvant Immunotherapy Combinations in Patients With Resectable Colon Cancer (NEST3)",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2028-12-16",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05790213",
"publication_url": "https://clinicaltrials.gov/study/NCT05790213",
"title": "Phase II Trial of Focal Prostate Ablation Combined With Androgen Deprivation Therapy for Prostate Cancer Treatment",
"has_exemption": false,
"start_date": "2025-05-05",
"completion_date": "2028-12-18",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07405476",
"publication_url": "https://clinicaltrials.gov/study/NCT07405476",
"title": "A Phase II Clinical Trial of Neoadjuvant Zanidatamab for HER2+ Localized Colorectal Cancer",
"has_exemption": false,
"start_date": "2026-04-07",
"completion_date": "2028-12-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07634601",
"publication_url": "https://clinicaltrials.gov/study/NCT07634601",
"title": "A Phase II Study of Elacestrant, an Oral Selective Estrogen Receptor Degrader (SERD) Combined With Everolimus in Patients With Recurrent or Metastatic ER-Positive (ER+) Endometrial Cancer (ELAVERA)",
"has_exemption": false,
"start_date": "2026-12-18",
"completion_date": "2028-12-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07405801",
"publication_url": "https://clinicaltrials.gov/study/NCT07405801",
"title": "A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Patients With Endocrine- Resistant Hormone-Receptor-Positive, HER2-Negative Advanced Breast Cancer With Chromosome 8P Loss and Without a PIK3CA Mutation",
"has_exemption": false,
"start_date": "2026-04-07",
"completion_date": "2028-12-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05723926",
"publication_url": "https://clinicaltrials.gov/study/NCT05723926",
"title": "Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation",
"has_exemption": false,
"start_date": "2026-01-09",
"completion_date": "2028-12-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Javelin Medical",
"sponsor_slug": "javelin-medical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04468659",
"publication_url": "https://clinicaltrials.gov/study/NCT04468659",
"title": "AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study With an Extension Phase to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer's Disease and Elevated Amyloid (A45 Trial) and in Subjects With Early Preclinical Alzheimer's Disease and Intermediate Amyloid (A3 Trial)",
"has_exemption": false,
"start_date": "2020-07-14",
"completion_date": "2028-12-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Eisai Inc.",
"sponsor_slug": "eisai-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06191315",
"publication_url": "https://clinicaltrials.gov/study/NCT06191315",
"title": "A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Longterm Safety of Dupilumab in Children 2 to <6 Years of Age With Uncontrolled Asthma and/or Recurrent Severe Asthmatic Wheeze",
"has_exemption": false,
"start_date": "2024-01-03",
"completion_date": "2028-12-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07460752",
"publication_url": "https://clinicaltrials.gov/study/NCT07460752",
"title": "MC250301, OptiOFS: A Randomized Phase II Trial of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Breast Cancer",
"has_exemption": false,
"start_date": "2026-05-22",
"completion_date": "2028-12-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07843498",
"publication_url": "https://clinicaltrials.gov/study/NCT07843498",
"title": "A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Once Weekly Petrelintide vs. Placebo in Participants With Overweight or Obesity",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-12-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07053423",
"publication_url": "https://clinicaltrials.gov/study/NCT07053423",
"title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Dupilumab on Airway Inflammation Through Assessments of Mucus Plugging and Other Lung Imaging Parameters in Patients With Chronic Obstructive Pulmonary Disease.",
"has_exemption": false,
"start_date": "2025-09-22",
"completion_date": "2028-12-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07205718",
"publication_url": "https://clinicaltrials.gov/study/NCT07205718",
"title": "An Open-label, Dose Escalation and Expansion, Phase 1/2 Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TAK- 188, an Anti-CCR8 Antibody-Drug- Conjugate, as a Single Agent in Adult Participants With Locally Advanced or Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2025-11-19",
"completion_date": "2028-12-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07748624",
"publication_url": "https://clinicaltrials.gov/study/NCT07748624",
"title": "VEX-AR: Randomized, Double-Blind, Placebo-Controlled, 52-Week Phase 2 Study Evaluating the Efficacy and Safety of Arumakimig (MAS825) in Participants With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome, Followed by an Open-Label Extension Period",
"has_exemption": false,
"start_date": "2026-10-30",
"completion_date": "2028-12-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01174121",
"publication_url": "https://clinicaltrials.gov/study/NCT01174121",
"title": "A Phase II Study Using Short-Term Cultured, Autologous Tumor-Infiltrating Lymphocytes Following a Lymphodepleting Regimen in Metastatic Cancers Plus the Administration of Pembrolizumab",
"has_exemption": false,
"start_date": "2010-08-26",
"completion_date": "2028-12-27",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT07220083",
"publication_url": "https://clinicaltrials.gov/study/NCT07220083",
"title": "A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled Trial to Assess the Effects of Oral TRPC6 Inhibitor BI 764198 Taken Over a 104 Week Treatment Period in Adult and Adolescent Participants With Primary Focal Segmental Glomerulosclerosis (pFSGS) or Genetic FSGS Related to TRPC6 Gene Variants",
"has_exemption": false,
"start_date": "2026-02-16",
"completion_date": "2028-12-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07716098",
"publication_url": "https://clinicaltrials.gov/study/NCT07716098",
"title": "A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression",
"has_exemption": false,
"start_date": "2026-07-23",
"completion_date": "2028-12-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05248659",
"publication_url": "https://clinicaltrials.gov/study/NCT05248659",
"title": "A Phase 2/3, Multicenter, Open-label Trial to Evaluate the Long-term Safety, Tolerability, and Efficacy of Sibeprenlimab Administered Subcutaneously in Subjects With Immunoglobulin A Nephropathy.",
"has_exemption": false,
"start_date": "2022-04-05",
"completion_date": "2028-12-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Otsuka Pharmaceutical Development & Commercialization, Inc.",
"sponsor_slug": "otsuka-pharmaceutical-development-commercialization-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07481981",
"publication_url": "https://clinicaltrials.gov/study/NCT07481981",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension",
"has_exemption": false,
"start_date": "2026-07-21",
"completion_date": "2028-12-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Insmed Incorporated",
"sponsor_slug": "insmed-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07728097",
"publication_url": "https://clinicaltrials.gov/study/NCT07728097",
"title": "A Phase 3b/4, Interventional, Prospective, Multicenter, Open-Label Study Evaluating the Effectiveness of a Gradual Titration Regimen to Optimize CBD-OS as Add-On Therapy in Adults With Lennox-Gastaut Syndrome",
"has_exemption": false,
"start_date": "2026-11-18",
"completion_date": "2028-12-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Jazz Pharmaceuticals",
"sponsor_slug": "jazz-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05035836",
"publication_url": "https://clinicaltrials.gov/study/NCT05035836",
"title": "A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)",
"has_exemption": false,
"start_date": "2021-11-16",
"completion_date": "2028-12-29",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06396039",
"publication_url": "https://clinicaltrials.gov/study/NCT06396039",
"title": "A Phase 4, Multicenter, Single-arm, Open-label Study to Evaluate the Effectiveness and Safety of Oral Ozanimod for Relapsing Multiple Sclerosis (RMS) in Chinese Participants",
"has_exemption": false,
"start_date": "2024-05-15",
"completion_date": "2028-12-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06855771",
"publication_url": "https://clinicaltrials.gov/study/NCT06855771",
"title": "A Multicenter, Randomized, Open-label, Phase 2 Study Evaluating the Safety and Efficacy of Navlimetostat (BMS-986504) Monotherapy and in Combination With Izalontamab Brengitecan in Participants With Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss After Progression on Prior Therapies",
"has_exemption": false,
"start_date": "2025-09-09",
"completion_date": "2028-12-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07204275",
"publication_url": "https://clinicaltrials.gov/study/NCT07204275",
"title": "A Phase 2b/3 Adaptive, Randomized, Active-controlled Study Evaluating the Efficacy, Safety, and Tolerability of Povetacicept Versus Calcineurin Inhibitor in the Treatment of Primary Membranous Nephropathy",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-12-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Vertex Pharmaceuticals Incorporated",
"sponsor_slug": "vertex-pharmaceuticals-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284849",
"publication_url": "https://clinicaltrials.gov/study/NCT07284849",
"title": "A Randomized, Double-Blind, Phase 3 Study of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer",
"has_exemption": false,
"start_date": "2026-03-05",
"completion_date": "2028-12-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07566195",
"publication_url": "https://clinicaltrials.gov/study/NCT07566195",
"title": "A Phase III, Multicentre, Open-Label, Chronic Dosing, Extension Study to Evaluate the Long-term Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations (ROMEO)",
"has_exemption": false,
"start_date": "2026-05-05",
"completion_date": "2028-12-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05183152",
"publication_url": "https://clinicaltrials.gov/study/NCT05183152",
"title": "Non-invasive Brain-computer Interfaces for Control of Assistive Devices",
"has_exemption": false,
"start_date": "2021-06-16",
"completion_date": "2028-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas at Austin",
"sponsor_slug": "university-of-texas-at-austin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05573308",
"publication_url": "https://clinicaltrials.gov/study/NCT05573308",
"title": "Optimizing Clear Aligners Efficiency With Remote Dental Monitoring and Artificial Intelligence Algorithms",
"has_exemption": false,
"start_date": "2022-10-17",
"completion_date": "2028-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05655182",
"publication_url": "https://clinicaltrials.gov/study/NCT05655182",
"title": "A Phase 1/2a Trial of the Safety, Tolerability and Immunogenicity of PIV5-vectored RSV Vaccine (BLB-201) in RSV Seronegative and Seropositive Infants and Children",
"has_exemption": false,
"start_date": "2023-03-09",
"completion_date": "2028-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Blue Lake Biotechnology Inc.",
"sponsor_slug": "blue-lake-biotechnology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05897086",
"publication_url": "https://clinicaltrials.gov/study/NCT05897086",
"title": "Nerve Repair Using Hydrophilic Polymers to Improve Tactile and Erogenous Neophallus Sensation",
"has_exemption": false,
"start_date": "2023-08-01",
"completion_date": "2028-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06483347",
"publication_url": "https://clinicaltrials.gov/study/NCT06483347",
"title": "Intra-tumor Delivery of Double Checkpoint Inhibitors, Chemodrug, and/or Bevacizumab Therapy as First Line for Inoperable Lung Cancer",
"has_exemption": false,
"start_date": "2024-04-04",
"completion_date": "2028-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Second Affiliated Hospital of Guangzhou Medical University",
"sponsor_slug": "second-affiliated-hospital-of-guangzhou-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06492421",
"publication_url": "https://clinicaltrials.gov/study/NCT06492421",
"title": "Phase II Study of Neoadjuvant CT-Guided Intra-tumor Double Checkpoint Blockades for Untreated Stage I-IIIA Non-Small Cell Lung Cancers Amenable for Surgical Resection",
"has_exemption": false,
"start_date": "2024-07-01",
"completion_date": "2028-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Second Affiliated Hospital of Guangzhou Medical University",
"sponsor_slug": "second-affiliated-hospital-of-guangzhou-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06492408",
"publication_url": "https://clinicaltrials.gov/study/NCT06492408",
"title": "Phase II Study of Neoadjuvant CT-Guided Intra-tumor Double Checkpoint Blockades for Untreated Hepatocellular Carcinoma (HCC) Amenable for Surgical Resection",
"has_exemption": false,
"start_date": "2024-07-01",
"completion_date": "2028-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Second Affiliated Hospital of Guangzhou Medical University",
"sponsor_slug": "second-affiliated-hospital-of-guangzhou-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06644833",
"publication_url": "https://clinicaltrials.gov/study/NCT06644833",
"title": "Effectiveness of Transcranial Magnetic Stimulation (TMS) Versus Treatment as Usual for First-Episode Depression in Adult Patients. An Open-Label Randomised Controlled Trial",
"has_exemption": false,
"start_date": "2025-01-01",
"completion_date": "2028-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sultan Qaboos University",
"sponsor_slug": "sultan-qaboos-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07526935",
"publication_url": "https://clinicaltrials.gov/study/NCT07526935",
"title": "Combined Role of Gastric Peroral Endoscopic Myotomy and Gastric Electrical Stimulator in the Management of Refractory Gastroparesis- A Randomized Single Blinded Control Trial",
"has_exemption": false,
"start_date": "2025-03-19",
"completion_date": "2028-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor Research Institute",
"sponsor_slug": "baylor-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06271707",
"publication_url": "https://clinicaltrials.gov/study/NCT06271707",
"title": "Left Sided Stellate Ganglion Blocks Impact on the Rate of Post-operative Atrial Fibrillation in Patients Undergoing Thoracic Surgery: A Pilot Study",
"has_exemption": false,
"start_date": "2025-05-19",
"completion_date": "2028-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07109726",
"publication_url": "https://clinicaltrials.gov/study/NCT07109726",
"title": "A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations",
"has_exemption": false,
"start_date": "2025-09-23",
"completion_date": "2028-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Terremoto Biosciences Inc.",
"sponsor_slug": "terremoto-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07122713",
"publication_url": "https://clinicaltrials.gov/study/NCT07122713",
"title": "Multi-institutional Prospective Pilot Study of Definitive Breast Radiation Therapy for Invasive Breast Cancer Patients Not Undergoing Definitive Surgery",
"has_exemption": false,
"start_date": "2025-12-08",
"completion_date": "2028-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Alexander Stessin",
"sponsor_slug": "alexander-stessin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04993027",
"publication_url": "https://clinicaltrials.gov/study/NCT04993027",
"title": "Topical Vancomycin for Infection Prophylaxis in Total Hip and Knee Arthroplasty",
"has_exemption": false,
"start_date": "2025-12-30",
"completion_date": "2028-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Alberta Hip and Knee Clinic",
"sponsor_slug": "alberta-hip-and-knee-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07179380",
"publication_url": "https://clinicaltrials.gov/study/NCT07179380",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study to Evaluate the Efficacy and Safety of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease",
"has_exemption": false,
"start_date": "2026-01-07",
"completion_date": "2028-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Insmed Incorporated",
"sponsor_slug": "insmed-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07162363",
"publication_url": "https://clinicaltrials.gov/study/NCT07162363",
"title": "Synergistic Intervention of Minimally Invasive Surgery and Deferoxamine in Intracerebral Hemorrhage (SMAD)",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2028-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07442461",
"publication_url": "https://clinicaltrials.gov/study/NCT07442461",
"title": "Effects of Visual Impairment on Neurophysiological Responses and the Feasibility and Impact of Multimodal Virtual Assistance for Instrumental Activities of Daily Living in Low Vision Populations",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2028-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07573462",
"publication_url": "https://clinicaltrials.gov/study/NCT07573462",
"title": "A PHASE 3, RANDOMIZED, DOUBLE-BLINDED TRIAL TO EVALUATE THE SAFETY AND TOLERABILITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS",
"has_exemption": false,
"start_date": "2026-05-04",
"completion_date": "2028-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}